These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 21030512)

  • 1. Protein misfolding and obstructive lung disease.
    Greene CM; McElvaney NG
    Proc Am Thorac Soc; 2010 Nov; 7(6):346-55. PubMed ID: 21030512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of proteases, endoplasmic reticulum stress and SERPINA1 heterozygosity in lung disease and α-1 anti-trypsin deficiency.
    Greene CM; Hassan T; Molloy K; McElvaney NG
    Expert Rev Respir Med; 2011 Jun; 5(3):395-411. PubMed ID: 21702661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanoimaging for protein misfolding diseases.
    Lyubchenko YL; Kim BH; Krasnoslobodtsev AV; Yu J
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2010; 2(5):526-43. PubMed ID: 20665728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ER chaperone-metal interactions: links to protein folding disorders.
    Tiffany-Castiglioni E; Qian Y
    Neurotoxicology; 2012 Jun; 33(3):545-57. PubMed ID: 22370090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Longitudinal measures of proteostasis in live neurons: features that determine fate in models of neurodegenerative disease.
    Skibinski G; Finkbeiner S
    FEBS Lett; 2013 Apr; 587(8):1139-46. PubMed ID: 23458259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for unfolded protein response activation in monocytes from individuals with alpha-1 antitrypsin deficiency.
    Carroll TP; Greene CM; O'Connor CA; Nolan AM; O'Neill SJ; McElvaney NG
    J Immunol; 2010 Apr; 184(8):4538-46. PubMed ID: 20228200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surviving protein quality control catastrophes--from cells to organisms.
    Schneider K; Bertolotti A
    J Cell Sci; 2015 Nov; 128(21):3861-9. PubMed ID: 26483388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular abnormalities linked to endoplasmic reticulum dysfunction in cerebrovascular disease--therapeutic potential.
    Paschen W; Mengesdorf T
    Pharmacol Ther; 2005 Dec; 108(3):362-75. PubMed ID: 16140387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Z α-1 antitrypsin deficiency and the endoplasmic reticulum stress response.
    Greene CM; McElvaney NG
    World J Gastrointest Pharmacol Ther; 2010 Oct; 1(5):94-101. PubMed ID: 21577302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Small-molecule modulation of cellular chaperones to treat protein misfolding disorders.
    Sloan LA; Fillmore MC; Churcher I
    Curr Opin Drug Discov Devel; 2009 Sep; 12(5):666-81. PubMed ID: 19736625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disease-associated amyloid and misfolded protein aggregates activate the inflammasome.
    Masters SL; O'Neill LA
    Trends Mol Med; 2011 May; 17(5):276-82. PubMed ID: 21376667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cellular responses to endoplasmic reticulum stress and apoptosis.
    Rasheva VI; Domingos PM
    Apoptosis; 2009 Aug; 14(8):996-1007. PubMed ID: 19360473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteostasis strategies for restoring alpha1-antitrypsin deficiency.
    Bouchecareilh M; Conkright JJ; Balch WE
    Proc Am Thorac Soc; 2010 Nov; 7(6):415-22. PubMed ID: 21030523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein folding stress in neurodegenerative diseases: a glimpse into the ER.
    Matus S; Glimcher LH; Hetz C
    Curr Opin Cell Biol; 2011 Apr; 23(2):239-52. PubMed ID: 21288706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Restoring endoplasmic reticulum function by chemical chaperones: an emerging therapeutic approach for metabolic diseases.
    Engin F; Hotamisligil GS
    Diabetes Obes Metab; 2010 Oct; 12 Suppl 2():108-15. PubMed ID: 21029307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The family of mammalian small heat shock proteins (HSPBs): implications in protein deposit diseases and motor neuropathies.
    Boncoraglio A; Minoia M; Carra S
    Int J Biochem Cell Biol; 2012 Oct; 44(10):1657-69. PubMed ID: 22484489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular chaperones as therapeutic targets to counteract proteostasis defects.
    Cattaneo M; Dominici R; Cardano M; Diaferia G; Rovida E; Biunno I
    J Cell Physiol; 2012 Mar; 227(3):1226-34. PubMed ID: 21618531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein quality control in the endoplasmic reticulum.
    Jørgensen MM; Bross P; Gregersen N
    APMIS Suppl; 2003; (109):86-91. PubMed ID: 12874956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emerging drugs for alpha-1-antitrypsin deficiency.
    Stockley RA
    Expert Opin Emerg Drugs; 2010 Dec; 15(4):685-94. PubMed ID: 20716026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The unfolded protein response--a stress signaling pathway of the endoplasmic reticulum.
    Shen X; Zhang K; Kaufman RJ
    J Chem Neuroanat; 2004 Sep; 28(1-2):79-92. PubMed ID: 15363493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.